1-800-FLOWERS.COM reiterated their reiterates rating on shares of Avidity Biosciences (NASDAQ:RNA – Get Rating) in a research report report published on Friday morning, Benzinga reports. RNA has been the topic of several other reports. Credit Suisse Group dropped their target price on shares of Avidity Biosciences from $35.00 to $30.00 and set an outperform rating […]
Shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Get Rating) have been assigned an average recommendation of “Buy” from the six analysts that are presently covering the firm, MarketBeat.com reports. Four equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12 […]
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Rating) shares fell 6.7% on Thursday . The stock traded as low as $16.12 and last traded at $16.17. 533,509 shares were traded during trading, a decline of 48% from the average session volume of 1,026,718 shares. The stock had previously closed at $17.34. Analyst Upgrades and Downgrades Several […]
1-800-FLOWERS.COM reissued their reiterates rating on shares of Avidity Biosciences (NASDAQ:RNA – Get Rating) in a research note released on Friday morning, Benzinga reports. A number of other research firms also recently weighed in on RNA. Chardan Capital reaffirmed a buy rating and set a $27.00 price objective on shares of Avidity Biosciences in a […]
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Rating)’s share price was down 6.7% during trading on Thursday . The stock traded as low as $16.12 and last traded at $16.17. Approximately 533,509 shares were traded during mid-day trading, a decline of 48% from the average daily volume of 1,026,718 shares. The stock had previously closed at […]